secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001628280-25-050412
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health receives NYSE delisting notice; plans reverse stock split
-----------------------------------------------------------------------

- NYSE notified agilon on Nov 5, 2025 that avg closing price was below $1.00 over 30 trading days ended Nov 4, 2025.
- Stock continues trading on NYSE during six-month cure period; no immediate impact on listing or business operations.
- To regain compliance, agilon intends to seek shareholder approval for a reverse stock split at 2026 annual meeting.
- Company must notify NYSE by Nov 19, 2025 of intent to remain listed and cure the deficiency.
- If reverse split approved and implemented, share price must promptly exceed $1.00 and stay above for at least 30 trading days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828025050412/0001628280-25-050412-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828025050412/agl-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-050412

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer